Article Text

other Versions

Download PDFPDF
Experience in managing independent clinical research, the best training strategy for future clinical pharmacists: the QOSMOS project
  1. Vera Damuzzo1,2,
  2. Laura Agnoletto3,
  3. Roberta Rampazzo4,
  4. Francesca Cammalleri5,
  5. Luca Cancanelli6,
  6. Marco Chiumente7,
  7. Stefano Costantino8,
  8. Silvia Michielan9,
  9. Federica Milani9,
  10. Alessia Sartori10,
  11. Daniele Mengato11
  1. 1Pharmacological sciences, Università degli Studi di Padova, Padova, Veneto, Italy
  2. 2ReNaSFO, Milan, Italy
  3. 3Azienda ULSS 5 Polesana, Rovigo, Veneto, Italy
  4. 4Pharmacy, Azienda ULSS 5 Polesana, Rovigo, Veneto, Italy
  5. 5Department of Pharmaceutical Sciences, University of Milan, Milano, Italy
  6. 6Hospital Pharmacy, Azienda ULSS n 2 Marca Trevigiana, Treviso, Veneto, Italy
  7. 7SIFaCT, Milan, Italy
  8. 8Department of Drug Science and Technology, University of Turin, Torino, Italy
  9. 9Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padova, Italy
  10. 10Department of Food and Drug, University of Parma, Parma, Italy
  11. 11Hospital Pharmacy, Bolzano Hospital, Bolzano, Italy
  1. Correspondence to Dr Daniele Mengato, Hospital Pharmacy, Bolzano Hospital, 39100 Bolzano, Italy; daniele.mengato{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The path to become a hospital pharmacist in Europe differs from nation to nation. In Italy, attendance at the postgraduate School of Hospital Pharmacy (SHP) is mandatory to work in the National Health System. Recent research published by the National Association of Hospital Pharmacy Students (ReNaSFO) highlighted a lack of education and participation in clinical research among students.1 Moreover, the internship programme, established by the Italian Ministry of University and Research, requires the participation in at least one multicentre clinical study during the SHP.2

To fill this gap, in 2017 the Italian Society for Clinical Pharmacy and Therapeutics (SIFaCT) and ReNaSFO established a joint action to improve …

View Full Text


  • Contributors VD, RR, MD, AL designed the study. CF, LC, CS, MS, MF, SA conducted the study. DM, VD, MC wrote the paper.

  • Funding None.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.